Works matching AU Lun Yan


Results: 94
    1
    2
    3

    MODY5 Hepatocyte Nuclear Factor 1ß (HNF1ß)-Associated Nephropathy: experience from a regional monogenic diabetes referral centre in Singapore.

    Published in:
    Journal of Investigative Medicine High Impact Case Reports, 2022, v. 10, p. 1, doi. 10.1177/23247096211065626
    By:
    • Hua Tan, Clara Si;
    • Ang, Su Fen;
    • Yeoh, Ester;
    • Goh, Bing Xing;
    • Loh, Wann Jia;
    • Shum, Cheuk Fan;
    • May Ping Eng, Molly;
    • Yan Lun Liu, Allen;
    • Wan Ting Chan, Lovynn;
    • Goh, Li Xian;
    • Subramaniam, Tavintharan;
    • Sum, Chee Fang;
    • Lim, Su Chi
    Publication type:
    Article
    4
    5

    real-world study on SGLT2 inhibitors and diabetic kidney disease progression.

    Published in:
    Clinical Kidney Journal, 2022, v. 15, n. 7, p. 1403, doi. 10.1093/ckj/sfac044
    By:
    • Liu, Allen Yan Lun;
    • Low, Serena;
    • Yeoh, Ester;
    • Lim, Eng Kuang;
    • Renaud, Claude Jeffrey;
    • Teoh, Selene Tse Yen;
    • Tan, Grace Feng Ling;
    • Chai, Chung Cheen;
    • Liu, Bo;
    • Subramaniam, Tavintharan;
    • Sum, Chee Fang;
    • Lim, Su Chi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 1957, doi. 10.1007/s00262-023-03390-x
    By:
    • Han, Cheng-Long;
    • Tian, Bao-Wen;
    • Yan, Lun-Jie;
    • Ding, Zi-Niu;
    • Liu, Hui;
    • Mao, Xin-Cheng;
    • Tian, Jin-Cheng;
    • Xue, Jun-Shuai;
    • Tan, Si-Yu;
    • Dong, Zhao-Ru;
    • Yan, Yu-Chuan;
    • Hong, Jian-Guo;
    • Chen, Zhi-Qiang;
    • Wang, Dong-Xu;
    • Li, Tao
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

    Published in:
    Expert Review of Anticancer Therapy, 2024, v. 24, n. 5, p. 303, doi. 10.1080/14737140.2024.2341723
    By:
    • Han, Cheng-Long;
    • Tian, Bao-Wen;
    • Yan, Lun-Jie;
    • Ding, Zi-Niu;
    • Liu, Hui;
    • Pan, Guo-Qiang;
    • Zhang, Xiao;
    • Mao, Xin-Chen;
    • Tan, Si-Yu;
    • Li, Rui-Zhe;
    • Wang, Dong-Xu;
    • Dong, Zhao-Ru;
    • Yan, Yu-Chuan;
    • Li, Tao
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 8, p. 1464, doi. 10.1111/jgh.16558
    By:
    • Cao, Qi‐Hang;
    • Liu, Hui;
    • Yan, Lun‐Jie;
    • Wang, Han‐Chao;
    • Ding, Zi‐Niu;
    • Mao, Xin‐Cheng;
    • Li, Rui‐Zhe;
    • Pan, Guo‐Qiang;
    • Zhang, Xiao;
    • Tian, Bao‐Wen;
    • Han, Cheng‐Long;
    • Dong, Zhao‐Ru;
    • Tan, Si‐Yu;
    • Wang, Dong‐Xu;
    • Yan, Yu‐Chuan;
    • Li, Tao
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50